Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Diabetes dosing still follows a gradual escalation schedule, starting at 0.25 mg weekly and increasing by 0.25 mg every four weeks
Researchers hope the drug may also reduce alcohol use by affecting the brains reward system
Altimmune announces FDA clearance of pemvidutide (ALT-801) IND for obesity
Tirzepatide is not a cure for diabetes, but it can be beneficial in controlling blood sugar levels and promoting weight loss
Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an fc fusion protein
This split, trial versus realworld reporting, is typical for side effects that are uncomfortable but not usually dangerous
US$ 29.27
US$ 20.15
US$ 28.45
US$ 25.26
